ID: ALA5200329

Max Phase: Preclinical

Molecular Formula: C35H35N7O3

Molecular Weight: 601.71

Representations

Canonical SMILES:  N#Cc1ccc(CN2CCC(NC(=O)c3ccc(C(=O)N4CCC(C(=O)c5ccc(-n6ccnc6)cc5)CC4)nc3)CC2)cc1

Standard InChI:  InChI=1S/C35H35N7O3/c36-21-25-1-3-26(4-2-25)23-40-16-13-30(14-17-40)39-34(44)29-7-10-32(38-22-29)35(45)41-18-11-28(12-19-41)33(43)27-5-8-31(9-6-27)42-20-15-37-24-42/h1-10,15,20,22,24,28,30H,11-14,16-19,23H2,(H,39,44)

Standard InChI Key:  JPJCNJIGUKSSPD-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 601.71

Molecular Weight (Monoisotopic): 601.2801

AlogP: 4.27

#Rotatable Bonds: 8

Polar Surface Area: 124.22

Molecular Species: NEUTRAL

HBA: 8

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 10

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 13.61

CX Basic pKa: 7.91

CX LogP: 2.71

CX LogD: 2.08

Aromatic Rings: 4

Heavy Atoms: 45

QED Weighted: 0.30

Np Likeness Score: -1.90

References

1. Shaw SJ, Goff DA, Carroll DC, Singh R, Sweeny DJ, Park G, Jenkins Y, Markovtsov V, Sun TQ, Issakani SD, Hitoshi Y, Payan DG..  (2022)  Structure activity relationships leading to the identification of the indirect activator of AMPK, R419.,  71  [PMID:35973281] [10.1016/j.bmc.2022.116951]

Source

Source(1):

• Scientific Literature